Antimicrobial Resistance Trends in Urinary Tract Infections in 6 African Countries - Summary - MDSpire

Antimicrobial Resistance Trends in Urinary Tract Infections in 6 African Countries

  • By

  • Lala Fanomezantsoa Rafetrarivony

  • Félix Cheysson

  • Dissou Affolabi

  • Cheikh Fall

  • Faridath Massou

  • Kaotar Nayme

  • Minone Rosanne Ngome

  • Andriniaina Rakotondrasoa

  • Thomas Bovagnet

  • Aboubakr Khazaz

  • Hugues Sanke-Waïgana

  • Gilles Stéphane Landry Ngaya

  • Jean-Robert Mbecko

  • Anne-Lise Beaumont

  • Chiara Crestani

  • Yakhya Dieye

  • Babacar Ndiaye

  • Abdou Diop

  • Pierrette Landrie Simo Tchuinte

  • Ariane Nzouankeu

  • Arsène Godlove Djoko Nono

  • Dimitri Rasoloson

  • Frédérique Randrianirina

  • Elisoa Hariniaina Ratsima

  • Lovasoa Ramparany

  • Sébastien Breurec

  • Tania Crucitti

  • Sylvain Brisse

  • Bich-Tram Huynh

  • July 9, 2026

  • 0 min

Share

Objective:

To investigate temporal trends in antimicrobial resistance (AMR) of E. coli and K. pneumoniae isolates from urine samples over 10 years in clinical laboratories of six African countries.

Approach:
  • Study Design: Cross-sectional study analyzing E. coli and K. pneumoniae isolates from urine samples collected in medical laboratories across six African countries from 2008 to 2023.
  • Data Collection: Data were collected from various clinical laboratories, focusing on outpatient and some inpatient specimens, with ethical approval obtained from relevant committees.
  • Microbiological Methods: Bacterial identification was performed using analytical profile index strips and Vitek systems, with antimicrobial susceptibility testing primarily by disk diffusion.
  • Statistical Analysis: Logistic regressions were used to model resistance levels, adjusting for age, sex, seasonality, and COVID-19 effects.
Key Findings:
  • E. coli and K. pneumoniae are major contributors to urinary tract infections in Africa.
  • Resistance mechanisms such as extended-spectrum β-lactamases (ESBLs) and carbapenemases are prevalent.
  • Data on resistance patterns are often scarce or fragmented, complicating interpretation.
Interpretation:

Monitoring resistance trends is essential for understanding AMR evolution and informing health policy and treatment strategies.

Limitations:
  • Data collection periods varied by country, potentially introducing bias.
  • Resistance patterns may vary by infection site, complicating the identification of temporal trends.
Conclusion:

The study highlights the need for comprehensive monitoring of AMR trends to inform public health strategies in Africa.

Original Source(s)

Related Content